Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Terguride Plus Symptomatic Therapy in Subjects With Diffuse Cutaneous Systemic Sclerosis
Phase of Trial: Phase III
Latest Information Update: 09 Feb 2018
At a glance
- Drugs Terguride (Primary)
- Indications Sclerosis
- Focus Therapeutic Use
- Sponsors Medac
- 09 Feb 2018 This trial has been suspended in Italy as per European Clinical Trials Database record.
- 29 Mar 2017 This trial has been suspended in Germany as per European Clinical Trials Database record.
- 29 Aug 2016 New trial record